- Home
- MFIN vs OSUR Comparison
MFIN vs OSUR Comparison
Compare MFIN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- OSUR
- Stock Information
- Founded
- MFIN 1995
- OSUR 2000
- Country
- MFIN United States
- OSUR United States
- Employees
- MFIN N/A
- OSUR N/A
- Industry
- MFIN Finance: Consumer Services
- OSUR Medical/Dental Instruments
- Sector
- MFIN Finance
- OSUR Health Care
- Exchange
- MFIN Nasdaq
- OSUR Nasdaq
- Market Cap
- MFIN 207.3M
- OSUR 223.0M
- IPO Year
- MFIN 1996
- OSUR 1986
- Fundamental
- Price
- MFIN $9.17
- OSUR $2.51
- Analyst Decision
- MFIN
- OSUR Hold
- Analyst Count
- MFIN 0
- OSUR 2
- Target Price
- MFIN N/A
- OSUR $5.50
- AVG Volume (30 Days)
- MFIN 43.3K
- OSUR 435.3K
- Earning Date
- MFIN 04-30-2025
- OSUR 05-07-2025
- Dividend Yield
- MFIN 4.80%
- OSUR N/A
- EPS Growth
- MFIN N/A
- OSUR N/A
- EPS
- MFIN 1.60
- OSUR N/A
- Revenue
- MFIN $316,751,000.00
- OSUR $161,626,000.00
- Revenue This Year
- MFIN N/A
- OSUR N/A
- Revenue Next Year
- MFIN $6.21
- OSUR $7.55
- P/E Ratio
- MFIN $5.72
- OSUR N/A
- Revenue Growth
- MFIN 13.93
- OSUR N/A
- 52 Week Low
- MFIN $6.48
- OSUR $2.69
- 52 Week High
- MFIN $10.50
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- MFIN 60.44
- OSUR 27.71
- Support Level
- MFIN $9.00
- OSUR $2.42
- Resistance Level
- MFIN $9.34
- OSUR $3.09
- Average True Range (ATR)
- MFIN 0.28
- OSUR 0.11
- MACD
- MFIN 0.04
- OSUR -0.03
- Stochastic Oscillator
- MFIN 79.76
- OSUR 13.24
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.